abundance of perceived “possibilities” for prevention rasts sharply with the difficulties that face preventive grammes. We argue that this situation has emerged from incomplete understanding of the process of prevention, Iving a mixture of biological factors, human decisioning and time perspectives. Based on examples, anlysis of the factors in the prevention process is presented.
Jenner E.An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox. London: The Author, 1798.
2.
Henderson D.Smallpox eradication: a WHO success story . World Health Forum1987; 8: 283–92.
3.
World Health Organization . Socioeconomic changes and health status: 1970–1980. In: World Health Organization Regional health report 1996. New Dehli: World Health Organization Regional Office for South-East Asia, 1996: 7.
4.
Breilh J.Epidemiology's role in the creation of a humane world: convergences and divergences among the schools . Soc Sci Med1995; 41: 911–14.
5.
Dillman D.Why innovation is difficult in government surveys . Journal of Official Statistics1996; 12: 113–24.
6.
U.S. Preventive Services Task Force . Guide to clinical preventive services. Second edition. Baltimore: Williams & Wilkins, 1996.
7.
Lorber B.Are all diseases infectious?Ann Intern Med1996; 125: 844–51.
8.
Edwards J.The importance of genetic disease and the need for prevention . Philos Trans R Soc Lond1988; B319: 211–27.
9.
Hesslow G.What is a genetic disease? On the relative importance of causes. In: Nordenfelt L , Lindahl BIB , eds. Health, disease, and causal explanations in medicine. Dordrecht: D Reidel, 1984: 183–93.
10.
Lindahl BIB , Johansson LA.Multiple cause-of-death data as a tool for detecting artificial trends in the underlying cause statistics: a methodological study . Scand J Soc Med1994; 22: 145–58.
11.
Collee J.A bacterial pathogen's view of the human condition . Postgrad Med J1995; 71: 709–11.
12.
Courvalin P.Impact of molecular biology on antibiotic susceptibility: testing and therapy . Am J Med1995; 99 (suppl 6A): 21S-25S.
13.
Botelho R , Skinner H.Motivating change in health behavior. Implications for health promotion and disease prevention . Prim Care1995; 22: 565–89.
14.
Law J.Risk and benefit associated with radiation dose in breast screening programmes — an update . Br J Radiol1995; 68: 870–6.
15.
Fischhoff B , Bostrom A , Quadrel MJ.Risk perception and communication . Annu Rev Public Health1993; 14: 183–203.
16.
Hill M.Diet and cancer: a review of scientific evidence . European Journal of Cancer Prevention1995; 4 (Suppl 2): 3–42.
17.
Verkasalo P , Pukkala E , Kaprio J , Heikkilä KV , Koskenvuo M.Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study . BMJ1996; 313: 1047–51.
18.
Charlton B.Should epidemiologists be pragmatists, biostatisticians, or clinical scientists?Epidemiology and Society1996; 7: 552–4.
19.
Taubes G.Epidemiology faces its limits . Science1995; 269: 164–65, 167–9.
20.
Annas G.Tobacco litigation as cancer prevention: dealing with the devil . N Engl J Med1997; 336: 304–8.
21.
Johnell O.Prevention of fractures in the elderly. A review . Acta Orthop Scand1995; 66: 90–8.
22.
World Health Organization . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. Geneva: World Health Organization, 1994. (WHO Tech Rep Ser; 843).
23.
Garfield E.The most-cited papers of all time, SCI 1945–1988. Part 1A. The SCI top 100 — Will the Lowry method ever be obliterated? In: Garfield E , ed. Journalology, key words plus, and other essays. Philadelphia, PA: ISI Press, 1991: 45–56. (Essays of an information scientist; Vol 13.)
24.
Ewald P.Evolution of infectious disease. Oxford: Oxford University Press, 1994.
25.
Popper K , Eccles JC.The self and its brain: an argument for interactionism. Berlin: Springer-Verlag, 1977.
